About Ipsum
Ipsum is a company based in Medellin (Colombia) founded in 2014. It operates as a Professional Services. Ipsum has raised $200 thousand across 1 funding round from investors including GITP Ventures. Ipsum offers products and services including Site Management Services, Clinical Research Services, and Technology Services. Ipsum operates in a competitive market with competitors including United BioSource Corporation, Launch Therapeutics, Xgene Pharmaceutical, Hikinger Pharmaceutical Technology and Concentrics Research, among others.
- Headquarter Medellin, Colombia
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$200 K (USD)
in 1 rounds
-
Latest Funding Round
$200 K (USD), Seed
Jul 02, 2015
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ipsum
Ipsum offers a comprehensive portfolio of products and services, including Site Management Services, Clinical Research Services, and Technology Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Patients are recruited and retained for efficient trial management.
Clinical research documents are designed per international standards.
Software solutions are provided for medical device companies.
Funding Insights of Ipsum
Ipsum has successfully raised a total of $200K through 1 strategic funding round. The most recent funding activity was a Seed round of $200 thousand completed in July 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $200,000
-
First Round
First Round
(02 Jul 2015)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2015 | Amount | Seed - Ipsum | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ipsum
Ipsum has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include GITP Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ipsum
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ipsum
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ipsum Comparisons
Competitors of Ipsum
Ipsum operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as United BioSource Corporation, Launch Therapeutics, Xgene Pharmaceutical, Hikinger Pharmaceutical Technology and Concentrics Research, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical support services
|
|
| domain | founded_year | HQ Location |
Late-stage clinical development services are provided for biopharma companies.
|
|
| domain | founded_year | HQ Location |
Developer of pharmaceutical products for treating neurological diseases and chronic pain
|
|
| domain | founded_year | HQ Location |
Phase I-IV drug research and development services are provided.
|
|
| domain | founded_year | HQ Location |
Late-stage (Phase II-IV trials) CRO
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Ipsum
When was Ipsum founded?
Ipsum was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Ipsum located?
Ipsum is headquartered in Medellin, Colombia. It is registered at Medellin, Antioquia, Colombia.
Is Ipsum a funded company?
Ipsum is a funded company, having raised a total of $200K across 1 funding round to date. The company's 1st funding round was a Seed of $200K, raised on Jul 02, 2015.
What does Ipsum do?
Ipsum is established as a prominent site management organization specializing in clinical trials with a focus on local expertise. Services are provided to biopharmaceutical companies to enhance their success probability through patient recruitment, trial preparation, management, and retention. Solutions are offered across various therapeutic areas including tropical diseases, cardiovascular, medical devices, and metabolic disorders. Trials are conducted at fewer sites with increased efficiency, ensuring consistent quality across the country. Collaboration with clients is emphasized to navigate the complex healthcare environment and bring innovative products to market.
Who are the top competitors of Ipsum?
Ipsum's top competitors include United BioSource Corporation, Xgene Pharmaceutical and Concentrics Research.
What products or services does Ipsum offer?
Ipsum offers Site Management Services, Clinical Research Services, and Technology Services.
Who are Ipsum's investors?
Ipsum has 1 investor. Key investors include GITP Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.